As Raymond James Financial (RJF) Shares Declined, Lateef Investment Management LP Decreased Holding by $527,268; As Novo (NVO) Share Price Rose, Holder Reynders Mcveigh Capital Management Has Decreased by $593,520 Its Holding

February 24, 2018 - By Nellie Frank

Reynders Mcveigh Capital Management Llc decreased its stake in Novo (NVO) by 12.69% based on its latest 2017Q3 regulatory filing with the SEC. Reynders Mcveigh Capital Management Llc sold 12,365 shares as the company’s stock rose 15.20% with the market. The institutional investor held 85,049 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $4.10 million, down from 97,414 at the end of the previous reported quarter. Reynders Mcveigh Capital Management Llc who had been investing in Novo for a number of months, seems to be less bullish one the $124.44 billion market cap company. The stock increased 1.64% or $0.87 during the last trading session, reaching $53.93. About 1.36 million shares traded. Novo Nordisk A/S (NYSE:NVO) has declined 23.93% since February 24, 2017 and is downtrending. It has underperformed by 40.63% the S&P500.

Lateef Investment Management Lp decreased its stake in Raymond James Financial Inc (RJF) by 2.2% based on its latest 2017Q3 regulatory filing with the SEC. Lateef Investment Management Lp sold 6,277 shares as the company’s stock declined 7.42% while stock markets rallied. The institutional investor held 279,489 shares of the finance company at the end of 2017Q3, valued at $23.57M, down from 285,766 at the end of the previous reported quarter. Lateef Investment Management Lp who had been investing in Raymond James Financial Inc for a number of months, seems to be less bullish one the $12.89 billion market cap company. The stock increased 1.54% or $1.39 during the last trading session, reaching $91.47. About 643,895 shares traded. Raymond James Financial, Inc. (NYSE:RJF) has risen 41.57% since February 24, 2017 and is uptrending. It has outperformed by 24.87% the S&P500.




Among 12 analysts covering Raymond James Financial Inc. (NYSE:RJF), 6 have Buy rating, 1 Sell and 5 Hold. Therefore 50% are positive. Raymond James Financial Inc. had 37 analyst reports since July 24, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Thursday, May 25 by Wood. As per Friday, October 28, the company rating was downgraded by JMP Securities. Citigroup maintained the shares of RJF in report on Monday, November 13 with “Neutral” rating. The firm earned “Neutral” rating on Monday, January 25 by Nomura. The rating was downgraded by Keefe Bruyette & Woods on Monday, December 5 to “Mkt Perform”. The firm has “Buy” rating by Buckingham Research given on Friday, October 27. The firm earned “Buy” rating on Friday, January 26 by Buckingham Research. The firm earned “Buy” rating on Thursday, July 13 by Nomura. The firm has “Sell” rating given on Thursday, November 30 by Credit Suisse. The firm earned “Buy” rating on Monday, October 26 by Citigroup.

Since December 11, 2017, it had 0 insider purchases, and 6 insider sales for $4.05 million activity. Shares for $455,000 were sold by ACKART JENNIFER C. $708,327 worth of stock was sold by Elwyn Tashtego S on Monday, January 29. On Thursday, December 14 REILLY PAUL C sold $1.11 million worth of Raymond James Financial, Inc. (NYSE:RJF) or 12,681 shares. Bunn James E sold $288,930 worth of stock or 3,000 shares. Catanese George had sold 506 shares worth $44,675 on Friday, December 15.

Investors sentiment decreased to 1.03 in 2017 Q3. Its down 0.21, from 1.24 in 2017Q2. It is negative, as 32 investors sold RJF shares while 143 reduced holdings. 56 funds opened positions while 125 raised stakes. 97.11 million shares or 0.18% less from 97.29 million shares in 2017Q2 were reported. Burney invested in 185,146 shares or 0.98% of the stock. Employees Retirement Sys Of Texas accumulated 60,000 shares. White Pine Cap Lc owns 16,305 shares or 0% of their US portfolio. Cardinal Capital Mgmt invested in 20,349 shares or 0.54% of the stock. Private Ltd Limited Liability Company, a Florida-based fund reported 218,994 shares. Kentucky Retirement System has invested 0.05% of its portfolio in Raymond James Financial, Inc. (NYSE:RJF). Skylands Cap Llc reported 44,600 shares. California State Teachers Retirement Systems holds 0.04% in Raymond James Financial, Inc. (NYSE:RJF) or 220,175 shares. 20,796 are owned by Bokf Na. Great West Life Assurance Can owns 85,840 shares for 0.02% of their portfolio. The New York-based Quantbot Technology Lp has invested 0% in Raymond James Financial, Inc. (NYSE:RJF). Laurion Capital Ltd Partnership has 0.01% invested in Raymond James Financial, Inc. (NYSE:RJF) for 23,657 shares. D E Shaw & Company Inc holds 0.01% of its portfolio in Raymond James Financial, Inc. (NYSE:RJF) for 73,224 shares. Atria Investments Limited Liability Co reported 0.07% stake. 72,058 were reported by Ngam Advsr Lp.

Lateef Investment Management Lp, which manages about $5.98 billion and $1.12B US Long portfolio, upped its stake in Allergan Plc by 18,678 shares to 201,873 shares, valued at $41.37M in 2017Q3, according to the filing.

Analysts await Raymond James Financial, Inc. (NYSE:RJF) to report earnings on April, 25. They expect $1.70 EPS, up 32.81% or $0.42 from last year’s $1.28 per share. RJF’s profit will be $239.47M for 13.45 P/E if the $1.70 EPS becomes a reality. After $1.61 actual EPS reported by Raymond James Financial, Inc. for the previous quarter, Wall Street now forecasts 5.59% EPS growth.

Analysts await Novo Nordisk A/S (NYSE:NVO) to report earnings on May, 2. They expect $0.66 earnings per share, up 13.79% or $0.08 from last year’s $0.58 per share. NVO’s profit will be $1.52B for 20.43 P/E if the $0.66 EPS becomes a reality. After $0.53 actual earnings per share reported by Novo Nordisk A/S for the previous quarter, Wall Street now forecasts 24.53% EPS growth.

Among 15 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 7 have Buy rating, 0 Sell and 8 Hold. Therefore 47% are positive. Novo Nordisk (ADR) had 21 analyst reports since August 28, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Friday, August 28 by Leerink Swann. The stock has “Overweight” rating by Morgan Stanley on Friday, December 1. The firm has “Equal-Weight” rating by Morgan Stanley given on Thursday, September 1. The stock of Novo Nordisk A/S (NYSE:NVO) earned “Neutral” rating by Piper Jaffray on Friday, September 23. BNP Paribas upgraded the stock to “Outperform” rating in Tuesday, September 13 report. The firm has “Hold” rating by J.P. Morgan given on Friday, December 29. The firm earned “Conviction Buy” rating on Monday, February 15 by Goldman Sachs. The stock of Novo Nordisk A/S (NYSE:NVO) earned “Buy” rating by Bank of America on Wednesday, December 6. JP Morgan upgraded the stock to “Neutral” rating in Friday, December 29 report. The firm earned “Buy” rating on Friday, January 19 by Goldman Sachs.

Reynders Mcveigh Capital Management Llc, which manages about $978.23 million and $766.91 million US Long portfolio, upped its stake in Xilinx Inc (NASDAQ:XLNX) by 14,100 shares to 128,947 shares, valued at $9.13M in 2017Q3, according to the filing. It also increased its holding in Canadian National Railway Co (NYSE:CNI) by 3,757 shares in the quarter, for a total of 263,444 shares, and has risen its stake in Biogen Inc (NASDAQ:BIIB).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.